Corpus Intelligence IC Memo — NWH PHYSICIANS SPECIALTY HOSPITAL 2026-04-26 08:05 UTC
IC Memo — NWH PHYSICIANS SPECIALTY HOSPITAL
Investment Committee Memorandum | AR | 20 beds | Grade D | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

NWH PHYSICIANS SPECIALTY HOSPITAL

CCN 040152 | WASHINGTON, AR | 20 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

NWH PHYSICIANS SPECIALTY HOSPITAL is a 20-bed suburban community hospital in WASHINGTON, AR with $19.2M in net patient revenue and a 26.6% operating margin. The hospital serves a payer mix of 19.3% Medicare, 13.7% Medicaid, and 67.1% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 26.6% to 33.9% (+736bps).

Net Revenue HCRIS$19.2M
Current EBITDA COMPUTED$5.1M
Operating Margin COMPUTED26.6%
Occupancy HCRIS23.1%
Revenue / Bed COMPUTED$958K
Net-to-Gross HCRIS19.0%
Distress Probability ML55.2%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
49
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 26.6% places it above the state median. Among 49 size-comparable peers (10-40 beds), the median margin is -13.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (10-40), prioritizing same-state peers. 49 hospitals in the comp set.

HospitalStateBedsRevenueMargin
NWH PHYSICIANS SPECIALTY HOSPI (Target)AR20$19.2M26.6%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%
OZARK HEALTH INCAR25$32.3M-4.7%
BAPTIST HEALTH MED CTR ARKADELAR25$30.1M-3.1%
HOWARD MEMORIAL HOSPITALAR20$26.5M-15.8%
MAGNOLIA REGIONAL HEALTH SYSTEAR29$25.9M-21.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$402K+210bp18mo
Cost to Collect4.5%2.5%$383K+200bp12mo
Denial Rate Reduction12.0%6.5%$379K+198bp12mo
A/R Days Reduction5200.0%3800.0%$233K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$402K
Cost to Collect
$383K
Denial Rate Reduction
$379K
A/R Days Reduction
$233K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$5.1M
+ RCM Uplift+$1.4M
Pro Forma EBITDA$6.5M
Current Margin26.6%
Pro Forma Margin33.9%
WC Released (1x)$735K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.8M$47.7M6.09x43.5%
Base (11x exit)10.0x11.0x$7.8M$55.0M7.02x47.7%
Bull Case9.0x11.0x$7.0M$62.2M8.82x54.6%
Bull (12x exit)9.0x12.0x$7.0M$69.9M9.92x58.2%
Bear Case11.0x10.0x$8.6M$38.1M4.42x34.6%
Bear (11x exit)11.0x11.0x$8.6M$44.7M5.19x39.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 23.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 49 hospitals with 10-40 beds
  • Same-state prioritization (n=50)
  • Comp margins: P25=-23.7% / P50=-13.9% / P75=-2.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.